Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

India Oxcarbazepine Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Oral Suspension), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Seizures and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2027

Growing cases of epilepsy in the country is expected to drive the growth of India oxcarbazepine market during the forecast period.Read More

India Levetiracetam Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Treatment (Myoclonic treatment, Tonic-clonic seizures treatment and Others), By Route of Administration (Oral v/s Intravenous), By Company, By Region, Forecast & Opportunities, FY2027

Growing epilepsy amongst population is expected to drive the growth of India levetiracetam market during the forecast period.Read More

India Piperacillin/Tazobactam Market By Route of Administration (Intravenous Injection v/s Intramuscular Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Intra-abdominal Infections, Nosocomial Pneumonia, Skin and Skin Structure Infections, Community acquired pneumonia and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2027

Growing cases of bacterial infections is expected to drive the growth of India piperacillin/tazobactam market during the forecast period.Read More

India Meropenem Market By Product Type (Meropenem Sodium v/s Meropenem Trihydrate), By Source (In-house v/s Contract Manufacturing Organizations), By Dose (500 mg/vial v/s 1gm/vial), By Distribution Channel (Online v/s Offline), By Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Increase in bacterial infections is expected to drive the growth of India meropenem market during the forecast period.Read More

India Vildagliptin Market By Composition (Monotherapy vs. Combination), By Source (In-house vs. Contract Manufacturing Organizations), By Strength (50 mg, 100mg, Others), By Distribution Channel (Online vs. Offline), By Application (Type 2 Diabetes Mellitus vs. Hyperglycaemia), By Company, By Region, Forecast & Opportunities, FY2026

Increasing diabetic population to drive the growth of the India vildagliptin market.Read More

Global Clinical Nutrition Market By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region, Competition, Forecast & Opportunities, 2025

Increasing cases of malnutrition and awareness among people towards health and fitness to drive global clinical nutrition marketRead More

India Rifampicin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Tuberculosis, Leprosy, Legionnaire's Disease and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026 FY2026

High prevalence of tuberculosis is expected to drive the growth of India rifampicin market during the forecast period.Read More

India Neomycin Market By Form (Tablet, Eye and Ear Drops, Ointment, Syrup and Injection), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral, Ophthalmic, Otic, Topical and Intravenous), By Type of Composition (Neomycin sulphate v/s neomycin palmitate), By Distribution Channel (Online v/s Offline), By Application (Ear Infection, Skin Infection, Ocular Infection and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

High prevalence of ear and ocular infections is expected to drive the growth of India neomycin market during the forecast period.Read More

India Ofloxacin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Cream, Syrup, Injection, Eye and Ear Drops), By Route of Administration (Oral, Intravenous, Topical, Ophthalmic and Otic), By Distribution Channel (Online v/s Offline), By Application (Chronic Bronchitis, Conjunctivitis, Acute Otitis Media, Skin Infections, Urinary Tract Infections and Cervical Gonorrhoea), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing need for advanced drugs to treat bacterial infection is expected to drive the growth of India ofloxacin market.Read More

India Erythromycin Market By Composition (Erythromycin Estolate v/s Erythromycin Stearate), By Application (Respiratory Tract Infections, Eye Infections, Ear Infections, Skin and Soft Tissue Infection, Gastro-intestinal Infections and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Tablet, Capsule, Injection, Ointment, Ear and Eye Drops), By Distribution Channel (Online v/s Offline), By Route of Administration (Oral, Topical, Intravenous, Otic and Ophthalmic), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

High prevalence of bacterial infections is expected to drive the growth of India erythromycin market during the forecast period.Read More

India Oxytetracycline Market By Type (Pharmaceutical Grade, Veterinary Grade), By Route of administration (Oral, Intravenous, Topical), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection, Ointment, Syrup), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infection, Respiratory Infection, Skin, Eye and Ear Infections and Others), By Company, By Region, Forecast & Opportunities, FY2026

Increase in number of infections is expected to drive the growth of India oxytetracycline market during the forecast period.Read More

India Diclofenac Sodium Market By Product Type (Prescription v/s OTC), By Form (Tablet, Injection, Gel, Others), By Application (Osteoarthritis, Ankylosing Spondylitis, Dysmenorrhea, Rheumatoid arthritis, Migraine, Pain and Others), By Route of Administration (Oral, Intravenous, Topical, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing cases of arthritis in the country is expected to drive the growth of India diclofenac sodium market during the forecast period.Read More

India Prednisolone Market By Form (Capsule, Tablet, Injection, Syrup, Eye Drops), By Route of Administration (Oral, Ophthalmic, Intravenous), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Inflammation, Rheumatoid Arthritis, Acute Lymphoblastic Leukaemia, Autoimmune Hepatitis and Others), By End User (Adult v/s Pediatric)), By Company, By Region, Forecast & Opportunities, FY2026

Increase in number of allergies is expected to drive the growth of India prednisolone market during the forecast period.Read More

India Levofloxacin Market By Strength (250 mg Tablets, 500 mg Tablets, 750 mg Tablets), By Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Others), By Form (Tablet, Capsule, Injection), By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing adoption of Levofloxacin for treating bacterial infections is expected to drive the growth of India levofloxacin market during the forecast period.Read More

India Streptomycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule and Injection), By Route of Administration (Oral v/s Intravenous), By Type of Manufacturing Process (Natural, Synthetic and Semi-synthetic), By Distribution Channel (Online v/s Offline), By Application (Tuberculosis, meningitis, throat Infection, endocarditis, brucellosis, plague, tularemia, rat bite fever and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing number of infectious diseases is expected to drive the growth of India streptomycin market during the forecast period.Read More

India Potassium Clavulanate Market By Composition (Single, Combinational), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Syrup, Injection), By Distribution Channel (Online v/s Offline), By Source (In-house v/s Contract Manufacturing Organizations), By Application (Respiratory Tract Infections, Skin Infections, UTI, Otitis media, Gynaecological infections, Bone and Joint Infections and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing occurrence of bacterial infections is expected to drive the growth of India potassium clavulanate market during the forecast period.Read More

India Levodopa Market By Drug Type (Rytary, Duopa, Sinemet, Caramet, Others), By Composition (Single, Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Distribution Channel (Online v/s Offline), By Application (Parkinson’s Disease, Dopamine Responsive Dystonia, Restless Legs Syndrome (RLS) and Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Increase in the prevalence of Parkinson’s disease is expected to drive the growth of India Levodopa market during the forecast period.Read More

India Carbamazepine Market By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection, Syrup, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Seizure, Bipolar Disorder, Trigeminal Neuralgia, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing cases of epilepsy in the country is expected to drive the growth of India carbamazepine market during the forecast period.Read More

India Cefixime Market By Route of Administration (Oral v/s Intravenous), By Dose (100 mg, 200 mg, 500 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Powder, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary tract infections, Otitis media, Pharyngitis and tonsillitis, Others), By End User (Adult v/s Children), By Company, By Region, Forecast & Opportunities, FY2026

Increase in bacterial infections is expected to drive the growth of India Cefixime market during the forecast period.Read More

India Metronidazole Market By Type of Process (Glyoxal Process, Ethidene Diamine Process, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral v/s Intravenous), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Product Type (Prescription v/s OTC), By Application (Dracunculiasis, Giardiasis, Trichomoniasis, Amebiasis, Bacterial Vaginosis, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of diseases is expected to drive the growth of India metronidazole market.Read More

Prev    Page 21 of 23 Next